Found: 78
Select item for more details and to access through your institution.
Deciphering the Metabolic Basis and Molecular Circuitry of the Warburg Paradox in Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 21, p. 3606, doi. 10.3390/cancers16213606
- By:
- Publication type:
- Article
Scaffold-mediated switching of lymphoma metabolism in culture.
- Published in:
- Cancer & Metabolism, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40170-022-00291-y
- By:
- Publication type:
- Article
Socioeconomic inequalities in treatment and relative survival among patients with diffuse large B-cell lymphoma: a Hong Kong population-based study.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97455-5
- By:
- Publication type:
- Article
Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 11, p. N.PAG, doi. 10.1007/s11912-020-00972-1
- By:
- Publication type:
- Article
Results of an international survey on the current organization of care for pregnant women with cancer.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2024, v. 103, n. 4, p. 751, doi. 10.1111/aogs.14748
- By:
- Publication type:
- Article
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross‐sectional survey.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1262, doi. 10.1111/bjh.19307
- By:
- Publication type:
- Article
Real‐world evidence of the safety and survival with CD19 CAR‐T cell therapy for relapsed/refractory solid organ transplant‐related PTLD.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 248, doi. 10.1111/bjh.18828
- By:
- Publication type:
- Article
End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 333, doi. 10.1111/bjh.18217
- By:
- Publication type:
- Article
First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 222, doi. 10.1111/bjh.16525
- By:
- Publication type:
- Article
Combinatorial ixazomib and belinostat therapy induces NFE2L2‐dependent apoptosis in Hodgkin and T‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 2, p. 295, doi. 10.1111/bjh.16160
- By:
- Publication type:
- Article
Important new developments in Hodgkin Lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 1, p. 6, doi. 10.1111/bjh.15736
- By:
- Publication type:
- Article
Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 212, doi. 10.1111/bjh.15255
- By:
- Publication type:
- Article
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 264, doi. 10.1111/bjh.14544
- By:
- Publication type:
- Article
How I manage patients with grey zone lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 3, p. 345, doi. 10.1111/bjh.14174
- By:
- Publication type:
- Article
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone ( CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma ( PTCL): final results from the T- cell consortium trial.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 535, doi. 10.1111/bjh.13855
- By:
- Publication type:
- Article
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 4, p. 514, doi. 10.1111/bjh.12915
- By:
- Publication type:
- Article
F-18 FDG- PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 793, doi. 10.1111/bjh.12824
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
Pre-diagnosis cigarette smoking and overall survival in non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 352, doi. 10.1111/bjh.12512
- By:
- Publication type:
- Article
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 55, doi. 10.1111/bjh.12488
- By:
- Publication type:
- Article
The genetic landscape of mutations in Burkitt lymphoma.
- Published in:
- Nature Genetics, 2012, v. 44, n. 12, p. 1321, doi. 10.1038/ng.2468
- By:
- Publication type:
- Article
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 833, doi. 10.1002/ajh.26527
- By:
- Publication type:
- Article
Dynamic analysis of human natural Killer cell response at single-cell resolution in B-cell non-hodgkin lymphoma.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01736
- By:
- Publication type:
- Article
Paradoxical Regulation of Hypoxia Inducible Factor-1α (HIF-1α) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081333
- By:
- Publication type:
- Article
Health-related quality of life in Hodgkin lymphoma: a systematic review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Improving Outcomes in PTLD.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 944
- By:
- Publication type:
- Article
Primary Cutaneous and Systemic Anaplastic Large Cell Lymphoma: Clinicopathologic Aspects and Therapeutic Options.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 7, p. 574
- By:
- Publication type:
- Article
Hodgkin Lymphoma in Older Patients; An Uncommon Disease in Need of Study.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1369
- By:
- Publication type:
- Article
Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2128373, doi. 10.1001/jamanetworkopen.2021.28373
- By:
- Publication type:
- Article
Highlights in Hodgkin Lymphoma From the 62nd American Society of Hematology Annual Meeting and Exposition: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 20
- By:
- Publication type:
- Article
Clinical, Morphologic, Immunophenotypic, and Molecular Cytogenetic Assessment of CD4--/CD8--γδ T-Cell Large Granular Lymphocytic Leukemia.
- Published in:
- American Journal of Clinical Pathology, 2011, v. 136, n. 2, p. 289, doi. 10.1309/AJCPTFFQ18JMYKDF
- By:
- Publication type:
- Article
Sustained Hematologic and Central Nervous System Remission with Single-Agent Denileukin Diftitox in Refractory Adult T-Cell Leukemia/Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 7, p. 472
- By:
- Publication type:
- Article
Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11098-5
- By:
- Publication type:
- Article
Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52985-x
- By:
- Publication type:
- Article
Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.725137
- By:
- Publication type:
- Article
The evolving role of response-adapted PET imaging in Hodgkin lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 108, doi. 10.1177/2040620715625615
- By:
- Publication type:
- Article
The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer.
- Published in:
- 2006
- By:
- Publication type:
- Letter
The Research on Adverse Drug Events and Reports (RADAR) Project.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 17, p. 2131, doi. 10.1001/jama.293.17.2131
- By:
- Publication type:
- Article
COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors.
- Published in:
- Journal of Cancer Survivorship, 2024, v. 18, n. 2, p. 439, doi. 10.1007/s11764-022-01236-6
- By:
- Publication type:
- Article
Current Treatment Options for Older Patients with Hodgkin Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Novel Targeted Agents for the Treatment of Hodgkin Lymphoma.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2010, v. 18, n. 1, p. 1
- By:
- Publication type:
- Article
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e435, doi. 10.1016/j.clml.2021.12.012
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
- By:
- Publication type:
- Article
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
- Published in:
- 2016
- By:
- Publication type:
- journal article